Wells Fargo’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$171K Buy
81,808
+33,205
+68% +$69.4K ﹤0.01% 4472
2025
Q1
$82.9K Sell
48,603
-1,851
-4% -$3.16K ﹤0.01% 4750
2024
Q4
$255K Buy
50,454
+14,649
+41% +$74K ﹤0.01% 4167
2024
Q3
$195K Sell
35,805
-418
-1% -$2.27K ﹤0.01% 4214
2024
Q2
$174K Buy
36,223
+10,027
+38% +$48.1K ﹤0.01% 4252
2024
Q1
$81.5K Buy
26,196
+6,992
+36% +$21.7K ﹤0.01% 4643
2023
Q4
$54.5K Buy
19,204
+3,629
+23% +$10.3K ﹤0.01% 4827
2023
Q3
$45.6K Sell
15,575
-12,571
-45% -$36.8K ﹤0.01% 4874
2023
Q2
$80.5K Buy
28,146
+13,894
+97% +$39.7K ﹤0.01% 4896
2023
Q1
$44K Buy
14,252
+11,302
+383% +$34.9K ﹤0.01% 4934
2022
Q4
$6.23K Sell
2,950
-540
-15% -$1.14K ﹤0.01% 5385
2022
Q3
$12K Sell
3,490
-237
-6% -$815 ﹤0.01% 5281
2022
Q2
$11K Buy
3,727
+777
+26% +$2.29K ﹤0.01% 5417
2022
Q1
$21K Hold
2,950
﹤0.01% 5646
2021
Q4
$21K Hold
2,950
﹤0.01% 5811
2021
Q3
$34K Buy
2,950
+1,450
+97% +$16.7K ﹤0.01% 5456
2021
Q2
$15K Hold
1,500
﹤0.01% 5677
2021
Q1
$16K Buy
+1,500
New +$16K ﹤0.01% 5846